Characteristics of the prevalence of highrisk human papilloma virus and its genotypes in women of the Gomel city /Gomel district
https://doi.org/10.58708/2074-2088.2025-4(36)-80-86
Abstract
Cervical cancer remains a serious public health problem. It is the fourth most common cancer in women worldwide, with an estimated 604,000 new cases and 342,000 deaths in 2020. Human papillomavirus (HPV) vaccination, combined with screening and treatment of precancerous lesions, is an effective and cost-effective method for preventing cervical cancer. Vaccination selection depends on the circulating HPV genotypes in different regions.
This article presents the prevalence of HPV and its genetic variants in women in Gomel city and the Gomel district. HPV genotypes 16, 51, and 58 were found to be most frequently detected, with their highest prevalence in the 18-24 age group and the 25-29 age group for cervical dysplasia. According to the obtained results, the tactics of conducting vaccination against high-risk HPV for the purpose of preventing cervical cancer are justified.
About the Authors
V. P. LohinavaBelarus
E. L. Gasich
Belarus
N. I. Shevchenko
Belarus
A. V. Voropaeva
Belarus
Zh. N. Miadzvedzeva
Belarus
E. A. Domonova
Russian Federation
References
1. Song, Q. Prevalence and Genotype Distribution of HPV in Hangzhou China / Q. Song, X. Wang // Clin Lab. – 2024. – Vol. 70, №6. – P. 1–8. https://doi.org/10.7754/Clin.Lab.2024.240139
2. Prevalence and genotype distribution of HPV infections among women in Chengdu, China / J. Zhang, T. Zha, X. Wang [et al.] // Virol J. – 2024. – Vol. 21, №1(52). – P. 1–14. https://doi.org/10.1186/s12985-024-02317-x
3. Вирус папилломы человека высокого канцерогенного риска: распространенность, связь с клинико-морфологическими характеристиками инвазивного рака шейки матки / Л.С. Мкртчян, В.И. Киселева, Б.В. Бойко [и др.] // Research’n Practical Medicine Journal. – 2023. – Т. 10, №4. – С. 104–118. https://doi.org/10.17709/2410-1893-2023-10-4-9
4. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries / H. Sung, J. Ferlay, R.L. Siegel [et al.] // CA Cancer J Clin. – 2021. – Vol. 71, №3. – P. 209–249. https://doi.org/10.3322/caac.21660
5. Логинова, О.П. Эпидемиологические аспекты распространенности рака шейки матки в Гомельской области / О.П. Логинова, Н.И. Шевченко И.В. Веялкин, Е.Л. Гасич // Здоровье и окружающая среда. – 2024. – Т. 34. – С. 340–346.
6. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. – URL: https://www.who.int/publications/i/item/9789240014107 (date of access: 26.09.2025).
7. WHO Cervical Cancer Prevention and Control Costing (C4P) tool. Geneva: World Health Organization. – URL: https://www.who.int/tools/who-cervical-cancer-prevention-and-control-costing-(c4p)-tool - (date of access: 26.09.2025).
8. Nayar, R. The Pap test and Bethesda / R. Nayar, D.C. Wilbur // Cancer Cytopathol. – 2015. – Vol. 123, №5. – P. 271–81. https://dx.doi.org/10.1002/cncy.21521
9. Prevalence of the human papillomavirus (HPV) types among cervical dysplasia women attending a gynaecological clinic in Sweden / F.R. García, J. Norenhag, G. Edfeldt [et al.] J. BJC Rep. – 2023. – Vol. 1, №1(11). – P. 1–7. https://doi.org/10.1038/s44276-023-00012-y
10. Prevalence and Distribution of High- and Low- Risk HPV Genotypes in Women Living in the Metropolitan Area of Naples: A Recent Update / E. Serretiello, F. Corrado, B. Santella [et al.] // Asian Pac J Cancer Prev. – 2023. – Vol. 24, №2. – P. 435–441. https://doi.org/10.31557/APJCP.2023.24.2.435
11. HPV integration and cervical cancer: a failed evolutionary viral trait / M.A. Molina, R.D. Steenbergen, A. Pumpe [et al.] // Trends Mol Med. – 2024. – Vol. 30, №9. – P. 890–902. https://doi.org/10.1016/j.molmed.2024.05.009
12. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana / Y. Nartey, K. Amo-Antwi, P. C. Hill [et al.] // PLoS One. – 2023. – Vol. 18, № 1(e0280437). – P. 1–16. https://doi.org/10.1371/journal.pone.0280437
13. Постановление Министерства здравоохранения Республики Беларусь от 17.05.2018 № 42 «О профилактических прививках»: в редакции от 01.07.2024 // Национальный правовой Интернет-портал Республики Беларусь. – URL: https://minzdrav.gov.by/upload/lcfiles/постановление_ МЗ_2024_111.pdf (дата обращения: 26.09.2025).
14. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis / L. Rodríguez-Carunchio, I. Soveral, R.D. Steenbergen [et al.] // BJOG. –2015. – Vol. 122, №1. – P. 119–127. https://doi.org/10.1111/1471-0528.13071
15. Lee, J.E. Untold story of human cervical cancers: HPV-negative cervical cancer / J.E. Lee, Y. Chung, S. Rhee, T.H. Kim // BMB Rep. – 2022. – Vol. 55, №9. – P. 429–438. https://doi.org/10.5483/BMBRep.2022.55.9.042
16. HPV-negative tumors of the uterine cervix / I. Nicolás, L. Marimon, E. Barnadas [et al.] // Mod Pathol. – 2019. – Vol. 32, №8. – P. 1189–1196. https://doi.org/10.1038/s41379-019-0249-1.
Supplementary files
Review
For citations:
Lohinava V.P., Gasich E.L., Shevchenko N.I., Voropaeva A.V., Miadzvedzeva Zh.N., Domonova E.A. Characteristics of the prevalence of highrisk human papilloma virus and its genotypes in women of the Gomel city /Gomel district. Medical and Biological Problems of Life Activity. 2025;(4):80-86. (In Russ.) https://doi.org/10.58708/2074-2088.2025-4(36)-80-86







